MOE International Joint Collaborative Research Laboratory for Animal Health and Food Safety & Jiangsu Engineering Laboratory of Animal Immunology, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
College of Artificial Intelligence, Nanjing Agricultural University, Nanjing, China.
Transbound Emerg Dis. 2022 Jul;69(4):1824-1836. doi: 10.1111/tbed.14161. Epub 2021 Jun 25.
One avian H3N2 influenza virus, providing its PB1 and HA segments, reassorted with one human H2N2 virus and caused a pandemic outbreak in 1968, killing over 1 million people. After its introduction to humanity, the pandemic H3N2 virus continued adapting to humans and has resulted in epidemic outbreaks every influenza season. To understand the functional roles of the originally avian PB1 gene in the circulating strains of human H3N2 influenza viruses, we analyzed the evolution of the PB1 gene in all human H3N2 isolates from 1968 to 2019. We found several specific residues dramatically changed around 2002-2009 and remained stable through to 2019. Then, we verified the functions of these PB1 mutations in the genetic background of the early pandemic virus, A/Hong Kong/1/1968(HK/68), as well as a recent seasonal strain, A/Jiangsu/34/2016 (JS/16). The PB1 V709I or PB1 V113A/K586R/D619N/V709I induced higher polymerase activity of HK/68 in human cells. And the four mutations acted cooperatively that had an increased replication capacity in vitro and in vivo at an early stage of infection. In contrast, the backward mutant, A113V/R586K/N619D/I709V, reduced polymerase activity in human cells. The PB1 I709V decreased viral replication in vitro, but this mutant only showed less effect on mice infection experiment, which suggested influenza A virus evolved in human host was not always consisted with highly replication efficiency and pathogenicity in other mammalian host. Overall, our results demonstrated that the identified PB1 mutations contributed to the viral evolution of human influenza A (H3N2) viruses.
一种禽流感 H3N2 流感病毒,其 PB1 和 HA 片段与一种人流感 H2N2 病毒重组,导致 1968 年的大流行爆发,造成超过 100 万人死亡。该大流行 H3N2 病毒在传入人类后继续适应人类,并导致每流感季节都有疫情爆发。为了了解最初来自禽类的 PB1 基因在流行的人源 H3N2 流感病毒株中的功能作用,我们分析了 1968 年至 2019 年所有人类 H3N2 分离株中 PB1 基因的进化。我们发现,大约在 2002-2009 年左右,有几个特定的残基发生了显著变化,并一直稳定到 2019 年。然后,我们在早期大流行病毒 A/Hong Kong/1/1968(HK/68)和最近的季节性毒株 A/Jiangsu/34/2016(JS/16)的遗传背景中验证了这些 PB1 突变的功能。PB1 V709I 或 PB1 V113A/K586R/D619N/V709I 诱导 HK/68 在人细胞中的聚合酶活性更高。并且这四个突变协同作用,在感染的早期阶段,在体外和体内的复制能力增加。相比之下,反向突变 A113V/R586K/N619D/I709V 降低了人细胞中的聚合酶活性。PB1 I709V 降低了病毒在体外的复制,但这种突变在小鼠感染实验中只显示出较小的效果,这表明流感 A 病毒在人类宿主中的进化并不总是与在其他哺乳动物宿主中的高复制效率和致病性一致。总的来说,我们的结果表明,鉴定出的 PB1 突变有助于人类流感 A(H3N2)病毒的进化。